| abstract |
Provided is a high dose tablet comprising 2-[[6-(3R)-3-amino-1-piperidinyl]-3, 4-dihydro-3-methyl-2, 4-dioxo-(1(2H)-pyrimidinyl)methyl]-4-fluorobenzonitrile (compound(A)) or salt thereof, as pharmaceutical active ingredient. The tablet comprises compound (A) or salt thereof, and a fludizing agent, and the content of compound (A) is 35 to 50 weight%. |